Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
作者信息
Morstyn G, Sheridan W, Lieschke G, Cebon J, Layton J, Fox R
机构信息
Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Victoria, Australia.
出版信息
Prog Clin Biol Res. 1990;354B:29-36.
PMID:1700441
Abstract
摘要
相似文献
1
Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
Prog Clin Biol Res. 1990;354B:29-36.
2
The therapeutic use of hematopoietic growth factors.造血生长因子的治疗用途。
J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):1-6. doi: 10.1016/S0091-6749(98)70185-X.
3
Granulocyte-macrophage colony-stimulating factor in neutropenia.
DICP. 1991 Jan;25(1):32-5.
4
Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.从粒细胞集落刺激因子改为粒细胞-巨噬细胞集落刺激因子的处方变更对接受骨髓抑制性化疗患者结局的影响。
Pharmacotherapy. 2005 Mar;25(3):372-8. doi: 10.1592/phco.25.3.372.61608.
5
[Acute myeloic leukemia: evaluation of colony-stimulating factors].
Dtsch Med Wochenschr. 2012 Nov;137(45):2306. doi: 10.1055/s-0032-1330135. Epub 2012 Oct 30.
6
A tale of two growth factors.
Pharmacotherapy. 2006 Mar;26(3):443-4; discussion 444. doi: 10.1592/phco.26.3.443.
7
Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.沙格司亭与非格司亭治疗化疗引起的中性粒细胞减少症的比较。
Am J Health Syst Pharm. 2005 Jan 1;62(1):83-7. doi: 10.1093/ajhp/62.1.83.
8
Granulocyte colony-stimulating factors.粒细胞集落刺激因子
Med Lett Drugs Ther. 1991 Jun 28;33(847):61-3.
9
[Place of CSF in pediatric oncology].
Pathol Biol (Paris). 1993 Jan;41(1):52.
10
Growth factor frenzy.
Exp Hematol. 1993 Jul;21(7):835-6.
Zotero 插件